Skip to content
healthcare.dev
Get a free key

Neostigmine Methylsulfate

NDC 63323-413, Neostigmine Methylsulfate, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-413
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203629
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-413 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE.5 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
63323-413-106332304131010 VIAL, MULTI-DOSE in 1 TRAY (63323-413-10) / 10 mL in 1 VIAL, MULTI-DOSE (63323-413-01)
63323-413-366332304133610 VIAL, MULTI-DOSE in 1 TRAY (63323-413-36) / 10 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=63323-413

Use it

Look up 63323-413 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-413 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.